Mangalam Drugs And Organics Limited has informed the Exchange about reasons for Delayed/Non-submission of Financial Results
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs And Organics Limited has submitted an explanation to the NSE regarding the delay or non-submission of its financial results within the required timeline. This is a compliance-related disclosure where the company is informing the exchange about why it could not file results on time. No specific financial figures, revenue, or profit numbers are mentioned in this announcement. The filing points to operational or administrative reasons behind the delay rather than any financial event.
This is typically a negative governance signal, as delayed financial reporting raises concerns about transparency and compliance. Retail investors should watch for the actual financial results once filed and check for any underlying issues such as auditor resignations, accounting concerns, or operational disruption that may have caused the delay.